← Leaderboards
Truman C Gamblin
Northwestern University
$3,388,057
Attributed
$4,336,115
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $508.1K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,336,115 · 8
By mechanism
R01$3,276,656 · 2
K02$510,316 · 1
R21$404,500 · 1
F32$115,413 · 1
P41$29,230 · 3
Top collaborators
- Mel B Feany4 shared
Most similar at Northwestern University
Same institution · by research overlap
- Michelle E King$275,157
- Sarah E Rice$3,938,093
Others in their field
Top investigators on “Tau Proteins”
- Paul S. Aisen · Cognition Therapeutics, Inc.$173,958,484
- Randall J Bateman · Washington University$147,724,903
- Reisa A. Sperling · Banner Health$127,010,151
- Eric Martin McDade · Washington University$96,907,662
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$80,063,338
- Michael W Weiner · Northern California Institute Res &Educ$78,790,916
Research focus
Tau ProteinsAlzheimer&AposProtein IsoformsIn VitroTau AggregationNeurodegenerative DisordersS DiseasePolymerizationNerve DegenerationMolecularMicrotubulesLaboratoriesPropertyTau PhosphorylationNeuronsFrontotemporal DementiaFilamentBiochemicalBinding (Molecular Function)ProteinsResearch StudyStructureLeadParkinsonian Disorders
Grant awards (21)
Development of in vitro disease-relevant strains of tau$404,500
R21 · FY2020 · AG · contact PI
Biochemical and in vivo determinants of tau neurotoxicity$459,914
R01 · FY2015 · NS
Biochemical and in vivo determinants of tau neurotoxicity$455,314
R01 · FY2014 · NS
Biochemical and in vivo determinants of tau neurotoxicity$472,747
R01 · FY2013 · NS
Biochemical and in vivo determinants of tau neurotoxicity$508,142
R01 · FY2012 · NS
Tau polymerization as a target for Alzheimer's disease$103,680
K02 · FY2010 · AG · contact PI
TAU FILAMENT-KU$4,300
P41 · FY2010 · RR · contact PI
Tau polymerization as a target for Alzheimer's disease$103,680
K02 · FY2009 · AG · contact PI
TAU FILAMENT-KU$8,699
P41 · FY2009 · RR · contact PI
Tau polymerization as a target for Alzheimer's disease$103,680
K02 · FY2008 · AG · contact PI
TAU FILAMENT-KU$16,231
P41 · FY2008 · RR · contact PI
Modulation of Tau function by AD-type Phosphorylation$262,629
R01 · FY2007 · AG · contact PI
Tau polymerization as a target for Alzheimer's disease$101,110
K02 · FY2007 · AG · contact PI
Modulation of Tau function by AD-type Phosphorylation$270,572
R01 · FY2006 · AG · contact PI
Tau polymerization as a target for Alzheimer's disease$98,166
K02 · FY2006 · AG · contact PI
Modulation of Tau function by AD-type Phosphorylation$277,380
R01 · FY2005 · AG
Modulation of Tau function by AD-type Phosphorylation$277,645
R01 · FY2004 · AG
Modulation of Tau function by AD-type Phosphorylation$292,313
R01 · FY2003 · AG
FATTY ACID INDUCED TAU POLYMERIZATION:EFFECTS OF OXID.$42,801
F32 · FY2002 · NS
FATTY ACID INDUCED TAU POLYMERIZATION:EFFECTS OF OXID.$40,196
F32 · FY2001 · NS
FATTY ACID INDUCED TAU POLYMERIZATION:EFFECTS OF OXID.$32,416
F32 · FY2000 · NS